11/01/1984 - "Ventricular tachycardia or fibrillation, inducible in all patients during the control study, could still be initiated by ventricular stimulation in 9 of 10 patients after bethanidine. "
07/01/1986 - "Bethanidine sulfate in paroxysmal ventricular tachycardia: toxicity and antifibrillatory actions."
11/01/1984 - "Acute electrophysiologic effects of bethanidine sulfate in patients with ventricular tachycardia or fibrillation."
05/01/1984 - "These results suggest that bethanidine acts to increase the refractory period and depresses conduction velocity in ischemically injured tissue, slowing the rate of ventricular tachycardia. "
10/01/1982 - "Bethanidine was given to 23 patients with recurrent multiple drug refractory ventricular tachycardia and fibrillation. "
|2.||Hypertension (High Blood Pressure)
07/01/1975 - "Systemic hemodynamic effects of bethanidine in essential hypertension."
08/23/1969 - "[Betanidine as a component of a combination therapy in severe hypertension]."
12/01/1968 - "Treatment of hypertension with bethanidine (esbatal)."
01/25/1968 - "[Betanidine (Esbatal, Regulin) in the therapy of hypertension]."
01/13/1968 - "Bethanidine in hypertension."
09/01/1985 - "In conclusion, the efficacy of bethanidine for preventing ventricular tachyarrhythmias as assessed by programmed stimulation is low. "
09/01/1985 - "Bethanidine sulfate: efficacy in prevention of ventricular tachyarrhythmias during programmed stimulation. "
05/01/1984 - "Bethanidine, in doses of 4, 8, and 16 mg/kg, slowed the cycle length of the tachycardia and allowed slower rates of ventricular pacing to produce equivalent delays at epicardial sites in the ischemic zone. "
05/01/1984 - "Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration."
05/01/1984 - "Before bethanidine sulfate was administered sustained ventricular tachyarrhythmias (VT) were inducible in 11 patients and reproducible nonsustained VT was induced in 3 patients. "
08/01/1984 - "These studies show that bethanidine is effective in preventing VT induction and, thus, its use may not be restricted only to cases of primary ventricular fibrillation."
09/01/1985 - "Patients presenting with only ventricular fibrillation may have a more favorable response to bethanidine sulfate. "
01/01/1982 - "The oral efficacy and rapid onset of action gives bethanidine a potential role in the prevention of out-of-hospital ventricular fibrillation."
01/01/1982 - "In the infarcted heart, bethanidine increased ventricular fibrillation threshold from an average postinfarction level of 14.4 mA to an average peak value of 55.3 mA, an increase of 327 percent. "
01/01/1982 - "Bethanidine increased ventricular fibrillation threshold in the normal dog heart from an average control value of 28.5 mA to an average peak value of 66.5 mA, an increase of 150 percent. "
|5.||Hypotension (Low Blood Pressure)
09/01/1985 - "Despite protriptyline administration in 54 of 59 bethanidine trials, symptomatic hypotension occurred in 30 trials (51%). "
10/01/1976 - "It may be concluded that the hypotensive effect of guanazodine is related to adrenergic neuron blocking action, the noradrenaline-depleting action in peripheral tissues is similar to the effect of guanethidine and bethanidine, and that the extent and the duration of the hypotension induced by guanazodine are approximately the same as those with guanethidine but appreciably greater than those with bethanidine. "
|8.||Sotalol (Sotalol Hydrochloride)
|10.||Ouabain (G Strophanthin)
|3.||Lower Body Negative Pressure